In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Pauline GilsonInstitut de Cancérologie de Lorraine, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche 7039 (UMR 7039), Université de Lorraine, 6 Avenue de Bourgogne, CS 30519, 54519 Vandœuvre-lès-Nancy, France.ORCID 0000-0001-6735-563X Marc MullerService de Biologie Moléculaire des Tumeurs, Département de Biopathologie, Institut de Cancérologie de Lorraine/CHRU Nancy, Rue du Morvan, 54511 Vandœuvre-lès-Nancy, France.ORCID 0000-0002-7190-7684 Guillaume GauchotteService d'Anatomie et Cytologie Pathologiques, Tumorothèque BB-0033-00035, Département de Biopathologie, Institut de Cancérologie de Lorraine/CHRU Nancy, Rue du Morvan, 54511 Vandœuvre-lès-Nancy, France.ORCID 0000-0001-5585-9195 Smahane FadilService de Biologie Moléculaire des Tumeurs, Département de Biopathologie, Institut de Cancérologie de Lorraine/CHRU Nancy, Rue du Morvan, 54511 Vandœuvre-lès-Nancy, France.
Marie HussonInstitut de Cancérologie de Lorraine, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche 7039 (UMR 7039), Université de Lorraine, 6 Avenue de Bourgogne, CS 30519, 54519 Vandœuvre-lès-Nancy, France.
Idrissia HanriotService de Biologie Moléculaire des Tumeurs, Département de Biopathologie, Institut de Cancérologie de Lorraine/CHRU Nancy, Rue du Morvan, 54511 Vandœuvre-lès-Nancy, France.
Andréa WitzService de Biologie Moléculaire des Tumeurs, Département de Biopathologie, Institut de Cancérologie de Lorraine/CHRU Nancy, Rue du Morvan, 54511 Vandœuvre-lès-Nancy, France.ORCID 0000-0002-1131-5193 Julie DardareService de Biologie Moléculaire des Tumeurs, Département de Biopathologie, Institut de Cancérologie de Lorraine/CHRU Nancy, Rue du Morvan, 54511 Vandœuvre-lès-Nancy, France.ORCID 0000-0002-5315-1852 Margaux BetzInstitut de Cancérologie de Lorraine, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche 7039 (UMR 7039), Université de Lorraine, 6 Avenue de Bourgogne, CS 30519, 54519 Vandœuvre-lès-Nancy, France.ORCID 0009-0003-2090-6918 Jean-Louis MerlinInstitut de Cancérologie de Lorraine, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche 7039 (UMR 7039), Université de Lorraine, 6 Avenue de Bourgogne, CS 30519, 54519 Vandœuvre-lès-Nancy, France.ORCID 0000-0001-8524-8897 Alexandre HarléInstitut de Cancérologie de Lorraine, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche 7039 (UMR 7039), Université de Lorraine, 6 Avenue de Bourgogne, CS 30519, 54519 Vandœuvre-lès-Nancy, France.ORCID 0000-0001-9548-6522 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Isocitrate dehydrogenase (
Indexed as
Hematologic NeoplasmsIsocitrate DehydrogenaseMutationNeoplasmsDNA Mutational AnalysisHigh-Throughput Nucleotide SequencingHumansSensitivity and SpecificityIDH1 protein, humanIDH2 protein, humanIsocitrate Dehydrogenaseimmunohistochemistryisocitrate dehydrogenasenext-generation sequencingpolymerase chain reaction
Identifiers
PMID41596663
PMCPMC12842437
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390